HomeInvesting NewsPfizer, Biontech, Moderna, Novavax to Gain in Passing of New Law

Pfizer, Biontech, Moderna, Novavax to Gain in Passing of New Law

Published on

To increase financing for American biomanufacturing, Biden will sign an executive order in a move poised to benefit pharmaceutical majors such as Pfizer, BioNTech, Moderna, and Novavax

Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX)

An executive order to increase support for the American biotechnology sector will be signed by President Joe Biden on Monday in an effort to lessen China’s reliance on American agricultural inputs, clean energy, and COVID-19 vaccinations.

Senior administration officials stated that Biden would give a speech in Boston on Monday following the signing of the order and that the White House would host a meeting on Wednesday to discuss the biotech effort and make investments to increase domestic R&D and production.

The executive order will lay out a plan for allocating federal financing to support domestic manufacturing for the use of microbes and biologically derived materials to develop a wide range of resources, including novel foods and fertilizers as well as pharmaceuticals and human tissues.

Biopharmaceutical Stocks to watch 

Producers of the COVID-19 vaccine, such as Pfizer (NYSE:PFE), BioNTech (BNTX), Moderna (MRNA), and Novavax (NVAX), as well as those who produce biodiesel, such as the Renewable Energy Group of Chevron (NYSE:CVX), Extreme Biodiesel (OTCPK:XTRM), and a company that produces genetically modified seeds, Corteva, Inc. (CTVA), could all benefit.

According to a Monday White House announcement, the Advanced Research Projects Agency for Health (ARPA-H), a newly founded organization to promote biomedical discoveries, will be led by Dr. Renee Wegrzyn, a veteran science advisor.

Dr. Wegrzyn is the Vice President for Business Development at Ginkgo Bioworks, a cell programming platform firm (DNA). A few weeks after President Biden issued an executive order to increase domestic semiconductor production, the government is making its latest effort to compete with China in the biomanufacturing sector.

Featured Image-  Megapixl @Boarding1now

Please See Disclaimer

Latest News

Rivian Stock: Explanation of this Week’s 19.1% Drop

Rivian Stock (NASDAQ:RIVN) S&P Global Market Intelligence data shows that Rivian stock dropped as high...

Friday’s 5% Tesla Stock Drop and Its Cause

Tesla Stock (NASDAQ:TSLA) The news that almost 1.1 million Tesla (NASDAQ:TSLA) vehicles were recalled swiftly...

The Reason Today’s Target Stock Fell Again

Target Stock (NYSE:TGT) Target stock continued to struggle during the trading week on Friday. This...

Here’s Why ChargePoint Stock Dropped Today

ChargePoint Stock (NYSE:CHPT) The ChargePoint stock fell today, along with several other riskier securities. At...

More like this

Apple Stock is the Last One Standing In Tech

Apple stock (NASDAQ:AAPL) is maintaining its strength despite a general downward trend in the...

Bitcoin Whale Transfers 1,678 Bitcoin Stock From Coinbase

Recently, a Bitcoin (BTC-USD) whale just sent off for trading $31,974,278 worth of Bitcoin...

Fubo Stock Rises as a Wedbush Analyst Upgrades the Company’s Ratings.

Following a recommendation to buy from Wedbush analyst Michael Pachter, FUBO stock (NYSE:FUBO) climbed...

Why Is FedEx Stock Rising?

FedEx Stock (NYSE:FDX) is increasing in value on Thursday afternoon following the company's announcement...

What Happened to the SPY Stock After the Fed’s Aggressive Rake Hike?

The SPY stock (NYSEARCA:SPY) has been in a slump since failing to reclaim the...

Analysts Think FedEx Corp Must Slash Costs as Investor Patience Wanes

Wall Street analysts said on Friday that FedEx Corp (NYSE:FDX) Corp's new chief executive...